Spliceosome-mediated trans-splicing: the therapeutic cut and paste - PubMed (original) (raw)

Review

. 2012 Aug;132(8):1959-66.

doi: 10.1038/jid.2012.101. Epub 2012 Apr 12.

Affiliations

Free article

Review

Spliceosome-mediated trans-splicing: the therapeutic cut and paste

Verena Wally et al. J Invest Dermatol. 2012 Aug.

Free article

Abstract

Spliceosome-mediated RNA trans-splicing (SMaRT) is an RNA-based technology to reprogram genes for diagnostic and therapeutic purposes. For the correction of genetic diseases, SMaRT offers several advantages over traditional gene-replacement strategies. SMaRT protocols have recently been used for in vitro phenotypic correction of a variety of genetic disorders, ranging from epidermolysis bullosa to neurodegenerative diseases. In vivo studies are currently bringing trans-splicing RNA therapy toward clinical application. In this review, we summarize the progress made toward the medical use of SMaRT and provide an outlook on its upcoming applications.

PubMed Disclaimer

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources